Ainos (NASDAQ:AIMD) Major Shareholder Carbon Nano Technology Taiwan Sells 41,000 Shares

Ainos, Inc. (NASDAQ:AIMD) major shareholder Carbon Nano Technology Taiwan sold 41,000 shares of the stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $2.36, for a total value of $96,760.00. Following the completion of the transaction, the insider owned 948,925 shares in the company, valued at approximately $2,239,463. This represents a 4.14% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Ainos Stock Down 19.0%

Shares of AIMD traded down $0.60 during trading hours on Wednesday, reaching $2.56. The stock had a trading volume of 1,873,740 shares, compared to its average volume of 893,030. Ainos, Inc. has a 12 month low of $1.26 and a 12 month high of $4.50. The firm has a 50-day simple moving average of $1.67 and a 200 day simple moving average of $1.83. The company has a current ratio of 0.55, a quick ratio of 0.50 and a debt-to-equity ratio of 1.58. The company has a market capitalization of $21.81 million, a price-to-earnings ratio of -0.89 and a beta of 2.29.

Ainos (NASDAQ:AIMD) last issued its earnings results on Wednesday, May 13th. The company reported ($0.41) earnings per share (EPS) for the quarter. Ainos had a negative return on equity of 160.55% and a negative net margin of 11,912.10%.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded Ainos from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Sell”.

Hedge Funds Weigh In On Ainos

A number of hedge funds have recently bought and sold shares of AIMD. Two Sigma Investments LP purchased a new position in Ainos during the 3rd quarter worth $80,000. Renaissance Technologies LLC boosted its holdings in Ainos by 13.1% during the 4th quarter. Renaissance Technologies LLC now owns 66,300 shares of the company’s stock worth $109,000 after acquiring an additional 7,700 shares during the last quarter. DRW Securities LLC boosted its holdings in Ainos by 272.6% during the 4th quarter. DRW Securities LLC now owns 66,211 shares of the company’s stock worth $109,000 after acquiring an additional 48,439 shares during the last quarter. Finally, Mariner LLC purchased a new position in Ainos during the 4th quarter worth $37,000.

Ainos Company Profile

Ainos, Inc (NASDAQ: AIMD) is a clinical?stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI?401, is an inhaled formulation of ibuprofen in a dry powder format.